The hesitation lies in balancing financial risk today with future health economics
If you're exploring whether Mounjaro is right for you or waiting for future treatments like Retatrutide once approved, our team is here to provide clear, medically guided support every step of the way.
This dual action creates conditions favorable for slow-wave sleep, the deepest and most restorative sleep phase
Recently, the STEP-HFpEF trial enrolled 529 non-diabetic patients with HFpEF and obesity, who were randomly assigned to receive either once-weekly semaglutide (2.4 mg) or placebo for 52 weeks
Obesity drugs that demonstrate benefits in cardiovascular disease, chronic kidney disease, sleep apnea, MASH, and metabolic syndrome may command stronger payer support and longer treatment duration